October 2023 FDA Recall Remedy Antifungal by Medline Industries, Lp - Northfield
D-0091-2024 - CGMP deviations

This Class II drug recall was voluntarily initiated by Medline Industries, Lp - Northfield on October 4, 2023 for the product Remedy Antifungal. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0091-2024

Reason for Recall
CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.
Initiated
10-04-2023
Reported
11-15-2023
Quantity

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
MEDLINE INDUSTRIES, LP - Northfield
Clinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0% w/w Antifungal, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, NDC: 53329-169-79

Batch or Lot Expiration Information

Lot# Lot 007782, Exp 08/31/2024

Affected Packages Involved in this Recall